Anaerobic bacteria-mediated tumor therapy has potential but is hindered by complex manufacturing processes, impaired targeting efficiency and side effects. Here, authors develop non-pathogenic anaerobic sulfate-reducing bacteria for in situ biosynthesis of ferrous sulfide nanoparticles for tumor-targeted therapy.
- Mengna Dong
- Xinhui Yang
- Qin Wang
